Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,210 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07417124RecruitingPhase 1
Safety of SNS851 in healthy volunteers
This early-phase trial tests a new investigational drug called SNS851 in healthy volunteers to see if it is safe and how the body handles it. It is a first step in understanding this treatment before testing it in people with a disease.
MelbourneAges 18–55 - NCT07418619Recruiting
Minimum exercise needed for inactive people
This trial looks at how little exercise you need to do to get health benefits. It is for people who are not physically active and want to find the easiest way to start moving more.
Tampere, PirkanmaaAges 30–55 - NCT07421258Recruiting
Study of treat-to-target in Crohn's and colitis
This study looks at how well a treat-to-target approach works for people with Crohn's disease or ulcerative colitis in everyday medical care. By reviewing your medical history over the past 2 years, researchers hope to learn how to better manage these conditions and prevent long-term damage.
Chongqing, Chongqing MunicipalityAges 20 years+ - NCT07421297RecruitingPhase 3
Study of SYH2053 for high cholesterol in Chinese adults
This trial tests a new medication called SYH2053 for people with high cholesterol or mixed high cholesterol and triglycerides. If you have high LDL cholesterol and are not taking strong cholesterol medicines, you may be able to join. The study will see if this drug is safe and works well.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07422207RecruitingPhase 1
Safety study of ME3241 in healthy adults
This trial is testing a new intravenous medicine (ME3241) for safety and how the body handles it. It's for healthy adults, so researchers can see how the drug works before testing it in people with the target condition.
Sydney, New South WalesAges 18–55 - NCT07422337Recruiting
Vaccine protection after blinatumomab for childhood leukemia
This study checks how well vaccines you got as a baby still protect you after treatment with blinatumomab for B-cell leukemia or lymphoma. It helps doctors understand if you may need extra vaccines.
Little Rock, ArkansasAges 1–23 - NCT07428499RecruitingPhase 3
Long-term safety of ADX-324 for hereditary angioedema
This study is for people who already finished a previous trial of the drug ADX-324 for hereditary angioedema. It tests the long-term safety and effectiveness of continuing the medication.
Litchfield Park, ArizonaAges 18 years+ - NCT07429006RecruitingPhase 1
First human trial of AKB-9090 in healthy adults
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
AucklandAges 18–60 - NCT07430956RecruitingPhase 3
Stroke prevention in atrial fibrillation without standard blood thinners
This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.
Dothan, AlabamaAges 18 years+ - NCT07433179RecruitingPhase 1
Testing SEP-479 in healthy adults
This trial tests a new medication called SEP-479 in healthy volunteers to see how the body handles it. Volunteers receive either a single dose or multiple doses of the drug as part of early safety research.
MelbourneAges 21–60 - NCT07434050RecruitingPhase 3
Study of XW003 for obesity with sleep apnea on CPAP therapy
This trial tests an investigational drug called XW003 to see if it helps people with obesity and obstructive sleep apnea who are already using a positive airway pressure (PAP) machine, like CPAP. It aims to improve weight loss and sleep apnea symptoms.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07435831Recruiting
Kimchi and gut health study
This trial tests whether eating kimchi every day for 3 weeks can improve gut health in people who are overweight. You'll be asked to eat study food daily and follow the study plan.
Davis, CaliforniaAges 19–70 - NCT07436260Recruiting
Comparing milk types and plant drink for metabolic health
This study compares the effects of two types of cow's milk (A2A2 and A1A2) and a plant-based drink on your metabolism (how your body uses energy). It may help you understand which milk option is better for your health.
Warsaw, Masovian VoivodeshipAges 30–60 - NCT07437105RecruitingPhase 1
Healthy volunteer study of VX-272 safety
This study tests a new investigational medicine called VX-272 in healthy volunteers. Researchers want to check its safety and how it moves through the body, so you would not have the condition the medicine is being developed for.
Tempe, ArizonaAges 18–55 - NCT07438444RecruitingPhase 4
Study of Tirzepatide for Type 2 Diabetes or Obesity
This trial tests a new medicine called tirzepatide to see if it helps people with type 2 diabetes or obesity. It is for adults in India who have not used insulin before or meet specific weight and health conditions.
AhmedabadAges 18 years+ - NCT07439263RecruitingPhase 1
First test of HB2198 in healthy adults
This study tests a single dose of an experimental therapy (HB2198) in healthy volunteers to see how the body handles it. It is a first-in-human trial designed to check safety and how the drug affects your immune system.
Bayswater, VictoriaAges Up to 55 years - NCT07439796RecruitingPhase 1
Study of ORN252 in healthy volunteers
This trial tests a new medicine called ORN252 in healthy people to see how safe it is. It helps researchers understand how the drug works before testing it in patients.
Herston, QueenslandAges 18–55 - NCT07441395RecruitingPhase 2
Study of soquelitinib for moderate to severe eczema
This trial tests an experimental pill called soquelitinib for people with moderate to severe eczema (atopic dermatitis). It aims to see if the drug can reduce symptoms like itching and skin inflammation.
South San Francisco, CaliforniaAges 18 years+ - NCT07442591RecruitingPhase 1
Study of WD-1603 dosing intervals in healthy adults
This study tests how a new medicine (WD-1603) is processed by the body when taken before meals at different time intervals. It is for healthy volunteers to help determine the best dosing schedule.
ShanghaiAges 18–55 - NCT07444476RecruitingPhase 3
Study of salanersen for spinal muscular atrophy (ages 15-60)
This trial tests a medicine called salanersen (BIIB115) to see how well it improves movement and how safe it is in people with spinal muscular atrophy (SMA). It includes those who have never taken an SMA drug or are currently on risdiplam and willing to switch.
Norfolk, VirginiaAges 15–60 - NCT07444788RecruitingPhase 1
Acute effects of 5-MeO-DMT in healthy people
This study tests a single dose of a fast-acting psychedelic called 5-MeO-DMT given through a vein. It is only for healthy volunteers who have no medical or mental health conditions and limited previous experience with hallucinogens.
Basel, Canton of Basel-CityAges 25–65 - NCT07444814RecruitingPhase 1
HWK-007 for advanced solid tumors
This trial tests a new drug called HWK-007, which is designed to target and attack cancer cells while sparing healthy ones. It is for people with specific advanced solid tumors (lung, endometrial, or ovarian cancer) that have not responded well to standard treatments.
Little Rock, ArkansasAges 18 years+ - NCT07445503Recruiting
High phenolic olive oil for metabolic health in central obesity
This trial tests whether a special olive oil rich in natural plant compounds (polyphenols) can improve metabolic health in people with belly fat. You may be eligible if you are an adult with overweight or obesity and have at least one related health issue like high blood pressure, high blood sugar, or abnormal cholesterol.
KalamataAges 18–80 - NCT07446101RecruitingPhase 1
Testing mirikizumab in healthy volunteers
This study is testing a new medicine called mirikizumab in healthy people to see how it works in the body. Healthy volunteers help researchers understand the drug's safety before it is studied in patients with a disease.
Daytona Beach, FloridaAges 18–65
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,210 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.